There are no conflicts of interest Emerging risk factors for the development of atrial fibrillation (AF) include a variety of breathing disorders. This question is addressed in the present issue of Heart Rhythm, in a study by Stevenson et al. 5 They used an anaesthetised sheep model of hypoxaemia and of hypercapnoea, permitting the required control over physiological and pathophysiological variables, and the measurement of detailed invasive atrial electrophysiological parameters relating to reentry, a prominent electrophysiological mechanism of AF. 6 The effective refractory period (ERP),
conduction velocity (θ), and their temporal and spatial heterogeneity were examined in both atria. Acute hypoxaemia was induced by replacing O 2 with N 2 while maintaining normal CO 2 , which reduced arterial O 2 saturation (SaO 2 ) to 80%. Neither this intervention, nor its acute reversal, significantly affected any of the electrophysiological measurements. By contrast, acute hypercapnoea, and its subsequent reversal, produced some intriguing changes in atrial electrophysiology. Hypercapnoea was induced with a re-breathing circuit while maintaining physiological SaO 2 (>98%) which elevated arterial CO 2 pressure (PaCO 2 ) to 97 mmHg. This resulted in a progressive increase in atrial ERP which peaked, at steady-state hypercapnoea, with a 52% prolongation over the normocapnoeaic value. Atrial conduction delay was also increased by hypercapnoea, slowing θ by up to 27%.
Hypercapnoea had no effect on the temporal or spatial heterogeneity of ERP or θ. Since the minimum pathlength for reentry, i.e., wavelength (λ), equals ERP x θ, 6 these changes in ERP and θ should produce an overall lengthening of λ and thus potentially inhibit reentry. The vulnerability to extrastimulus-induced AF was assessed at that point, and AF could not be induced. 5 However, strikingly, well after full reversal of hypercapnoea, while the ERP had recovered to pre-hypercapnoeaic levels, θ remained slowed by up to 22%, thus potentially shortening λ at that time. This coincided with an increased vulnerability to inducible AF.
A consideration of the potential underlying mechanisms and clinical implications of these findings raises some intriguing questions and possibilities for future study. For example, how did elevated PaCO 2 increase ERP and slow θ, and why did the θ-slowing persist after the reversal of hypercapnoea while the ERP-increase did not?
The mechanisms underlying the changes in ERP and θ were not specifically investigated. 5 ERP is determined by Na + current (I Na ) reactivation, which depends largely on action potential duration (APD). APD is determined by the relative magnitude of ion currents flowing during repolarisation. 6 Hypercapnoea caused a significant decrease in serum pH, which reversed when PCO 2 was returned to normal, 5 and since the ERP changes were co-incident with these pH changes, one might suspect a causal link between them. However, this seems unlikely, since acidosis may actually shorten APD and ERP, by increasing a steady-state outward current. θ is determined by action potential maximum upstroke velocity (V max ), which depends mainly on I Na , and also by gap junction current (I gap ), which reflects the degree of intercellular electrical coupling. either during hypercapnoea or following its reversal, may have been insufficient to account for the observed θ-slowing; depolarising V m by a maximum of only approximately 3 mV. Alternative explanations for the hypercapnoea-induced θ-slowing could include a reduction in I gap since, in canine ventricle, hypercapnoeaicacidosis slowed θ preferentially in the transverse direction, which may be determined by I gap rather than I Na . 9 However, such an effect on I gap would need to persist for ≥2 hours after the hypercapnoea-reversal to explain the associated persistent θ-slowing 5 via this mechanism. Why did hypoxaemia have no effect on atrial ERP or θ?
Hypoxaemia may be expected to not affect atrial electrophysiology as long as PCO 2 and pH are controlled, as here, 5 and consistent with the majority of reports discussed by Stevenson et al. 5 However, this may differ under more physiological conditions, in the presence of a functioning autonomic nervous system. Did the persistent θ-slowing observed after the reversal of hypercapnoea actually cause the associated increased vulnerability to AF?
This will require further investigation, since propagation of activation of the beat immediately preceding the onset of AF was not mapped, and non-reentrant activity could also have been involved. values, were found to prolong ERP. 5 Nevertheless, it is unknown whether such intermediate values could also have slowed atrial θ, since θ was not measured until PaCO 2 had reached ~97 mmHg. Moreover, it is also unknown whether the AF-promoting persistent θ-slowing plus ERP-shortening that was observed 5 would occur following reversal of PCO 2 from clinically relevant hypercapnoeaic levels, rather than from ~97 mmHg. If so, then such a mechanism would be most applicable to SDB, involving cyclical hypercapnoeaic episodes, rather than to COPD with chronically maintained hypercapnoea. It should be recognised that obstructive airways diseases cause combined hypoxaemia and hypercapnoea, and also that associated influences of increased adrenergic activity are expected to have wide-ranging and complex effects on atrial electrophysiology, intracellular Ca 2+ -handling, and propensity to AF (see 12 for review).
Stevenson et al 5 have provided provocative data on effects of hypercapnoea, and on a lack of effect of hypoxaemia, on atrial electrophysiology and susceptibility to AF, the mechanisms of which warrant further study.
These data should be taken into account when considering the multiple mechanisms linking breathing disorders with the development of AF.
